The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 11, Pages e0143429
Publisher
Public Library of Science (PLoS)
Online
2015-11-25
DOI
10.1371/journal.pone.0143429
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
- (2015) Mohammed Eslam et al. Nature Communications
- Review article: genetic factors that modify the outcome of viral hepatitis
- (2014) A. F. Stättermayer et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study
- (2014) Jennifer C Price et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
- (2014) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Progression to advanced liver fibrosis in HIV/HCV-coinfected patients and prioritization of new hepatitis C therapies
- (2014) Pablo Labarga et al. ANTIVIRAL THERAPY
- Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients
- (2014) Juan Macías et al. EXPERT OPINION ON PHARMACOTHERAPY
- Patatin-like phospholipase domain-containing protein 3 and Liver Disease: Opportunities to Unravel Mechanisms Underlying Statistical Associations
- (2014) Jérôme Boursier et al. HEPATOLOGY
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs
- (2013) Monica A. Konerman et al. HEPATOLOGY
- Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration
- (2013) L Castera et al. HIV MEDICINE
- HIV and co-infections
- (2013) Christina C. Chang et al. IMMUNOLOGICAL REVIEWS
- Pathogenesis of Accelerated Fibrosis in HIV/HCV Co-infection
- (2013) Wenyu Lin et al. JOURNAL OF INFECTIOUS DISEASES
- Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels
- (2013) M. Mandorfer et al. JOURNAL OF VIRAL HEPATITIS
- Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C
- (2013) R. Zampino et al. JOURNAL OF VIRAL HEPATITIS
- Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin
- (2013) Mattias Mandorfer et al. LIVER INTERNATIONAL
- Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II)
- (2013) Markus Peck-Radosavljevic et al. WIENER KLINISCHE WOCHENSCHRIFT
- Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV–hepatitis C virus coinfected patients
- (2012) Mattias Mandorfer et al. AIDS
- Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin
- (2012) L. Valenti et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A prospective evaluation of pulmonary, systemic and hepatic hemodynamics in HIV-HCV coinfected patients prior and after antiviral therapy with pegylated interferon and ribavirin
- (2012) Thomas Reiberger et al. ANTIVIRAL THERAPY
- Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase
- (2012) Manju Kumari et al. Cell Metabolism
- Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C
- (2012) Albert Friedrich Stättermayer et al. JOURNAL OF HEPATOLOGY
- Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience
- (2012) Thomas Reiberger et al. WIENER KLINISCHE WOCHENSCHRIFT
- IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients
- (2011) Berit A. Payer et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C
- (2011) Eric Trépo et al. HEPATOLOGY
- Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
- (2011) Karin Neukam et al. JOURNAL OF HEPATOLOGY
- Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients Receiving Antiretroviral Therapy
- (2011) Pablo Barreiro et al. JOURNAL OF INFECTIOUS DISEASES
- Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C
- (2011) M. Sasso et al. JOURNAL OF VIRAL HEPATITIS
- Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein
- (2010) Stefano Romeo et al. CURRENT OPINION IN LIPIDOLOGY
- Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
- (2010) Luca Valenti et al. HEPATOLOGY
- Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy
- (2010) E.A. Tsochatzis et al. JOURNAL OF HEPATOLOGY
- Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes
- (2010) Magali Sasso et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Coinfection With HIV-1 and HCV—A One-Two Punch
- (2009) Arthur Y. Kim et al. GASTROENTEROLOGY
- Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus
- (2009) Juan Macías et al. HEPATOLOGY
- HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension
- (2009) T. Reiberger et al. JOURNAL OF VIRAL HEPATITIS
- Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
- (2008) Hla-Hla Thein et al. AIDS
- Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection
- (2008) T. Reiberger et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection
- (2008) Richard K. Sterling et al. HEPATOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started